GO Vertical ICM · In the media
Safety beyond regulatory approval.
Michael Khoury on the evidence, engineering and monitoring that support long-term device performance.
MEDICAL DEVICE NETWORK · NOVEMBER 3, 2026
Regulatory approval is a major milestone in medical-device development. What happens afterward deserves just as much attention.
Michael Khoury, CEO of GO Vertical ICM, contributed expert commentary to Medical Device Network’s feature, “Spinal cord stimulator lawsuits surge: what is going wrong?”
The article examines litigation involving spinal cord stimulators and the questions it raises about device modifications, clinical evidence and long-term performance.
Performance matters throughout the lifecycle.
Michael’s contribution focuses on the relationship between regulatory approval and performance in everyday use. He explains that safety depends on more than initial design validation: manufacturing consistency, implantation, programming and performance over time also matter.
“Approval is not a lifetime guarantee of safety.”
Michael Khoury · CEO, GO Vertical ICM
Quoted in Medical Device Network
The development perspective
A connected lifecycle, not a single checkpoint.
01 / Engineering
Design + verify
Understand risks and changes.
02 / Evidence
Validate + evaluate
Connect claims to evidence.
03 / Manufacturing
Build consistently
Control process and quality.
04 / Post-market
Monitor + learn
Investigate performance over time.
The questions behind the milestone.
Michael does not automatically attribute the litigation to a flawed FDA approval process. Instead, he highlights questions about whether evolving devices, supporting evidence and emerging risks have been adequately evaluated throughout development and use.
His broader message extends beyond spinal cord stimulators: engineering verification, clinical validation, risk management and post-market monitoring should remain connected throughout a product’s lifecycle.
Plan for the evidence you will need next.
For innovation teams, this offers a practical planning question: what evidence will support the product after launch, as well as before it?
At GO Vertical ICM, we encourage founders to consider development, manufacturing, regulatory strategy and commercialization together. Decisions made early can shape the evidence, resources and expertise needed later.
Start with a clear plan
Define the next stage of your innovation.
Strategic Discovery helps assess priorities and shape a practical development roadmap.
Medical Device Network · November 3, 2026
Read the full article and Michael’s commentary ↗
This post summarizes published expert commentary. The underlying article discusses litigation; allegations are not presented here as established findings.